Cardio-Renal Division Acting Director To Be Throckmorton; Lipicky Retires

Deputy Director Douglas Throckmorton, MD, will be acting director of FDA's Division of Cardio-Renal Drug Products starting Feb. 28, when long-time Division Director Raymond Lipicky, MD, retires